Summary
-
1.
The effects of dl-α-difluoromethylornithine (RMI 71782; DFMO) on the tumours induced in female rats by a single oral administration of 20 mg 7,12-dimethylbenz[a]anthracene (DMBA) have been investigated.
-
2.
Treatment with DFMO (2% aqueous solution as sole drinking fluid) starting 30 days after administration of DMBA resulted in markedly fewer animals with tumours and >90% reduction in the total number of tumours.
-
3.
In rats bearing at least one palpable tumour, treatment with DFMO (2% in the drinking water) slowed significantly the rate of appearance of new tumours but affected to only a minimal extent the growth of existing tumours. Tumour ornithine decarboxylase activities and putrescine concentrations were reduced by treatment with DFMO; the activity of S-adenosyl-l-methionine decarboxylase was increased and the concentration of spermine either remained unchanged or increased depending on the length of treatment.
-
4.
Cyclophosphamide, 100 mg/kg, injected once then repeated after 10 days, altered neither the rate of appearance of new tumours nor the growth of the existing tumours. Combined treatment with DFMO plus cyclophosphamide resulted in regression of the majority of tumours existing at the start of treatment and a marked reduction in the rate of appearance of new tumours.
-
5.
In conclusion, DFMO has clear antitumoral activity against the rat mammary tumour induced by DMBA. The effects are manifested principally as a decreased rate of tumour appearance but meaningful effects on tumour growth are observed if the drug is administered during early tumour development or in combination with cyclophosphamide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartholeyns J, Koch-Weser J (1981) Effects of α-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice and HTC solid tumors in rats. Cancer Res 41:5158–5161
Bey P (1978) Substrate-induced irreversible inhibition of α-aminoacid decarboxylases. Application to glutamate, aromatic-l-α-aminoacid and ornithine decarboxylases. In: Seiler N, Jung MJ, Koch-Weser J (eds) Substrate-induced irreversible inhibitors. Elsevier/North Holland Biomedical Press, Amsterdam, pp 27–41
Calabresi P, Parks RE (1980) Antiproliferative agents and drugs used for immunosuppression. In: Goodman Gilman A, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 1256–1313
Fozard JR, Prakash NJ (1981) Effects of dl-α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene. Naunyn-Schmiedeberg's Arch Pharmacol 316:Suppl R7
Fozard JR, Koch-Weser J (1982) Pharmacological consequences of inhibition of polyamine biosynthesis with dl-α-difluoromethylornithine. Trends Pharmacol Sci 3:107–110
Grove J, Fozard JR, Mamont PS (1981) Assay of α-difluoromethylornithine in body fluids and tissues by automatic amino-acid analysis. J Chromat 223:409–416
Heston WDW, Lazan DW, Fair WR (1981) Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R 3327AT prostate-derived tumor. Cancer Lett 11:323–330
Huggins C, Grand LC, Brillantes FP (1961) Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature (Lond) 189:204–207
Jänne J, Pösö H, Raina A (1978) Polyamines in rapid growth and cancer. Biochim Biophys Acta 473:241–294
Jänne J, Alhonen-Hongisto L, Seppänen P, Siimes M (1981) Use of polyamine antimetabolites in experimental tumors and in human leukemia. Med Biol (in press)
Kellen JA, Chan AW-L, Mirakian A (1980) Effect of α-difluoromethyl ornithine on the transplantable rat hepatoma 5123, 1-1. Res Commun Chem Pathol Pharmacol 30:377–380
Luk GD, Marton LJ, Baylin SB (1980) Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science 210:195–198
Mamont PS, Duchesne M-C, Grove J, Bey P (1978a) Anti-proliferative properties of dl-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun 81:58–66
Mamont PS, Duchesne M-C, Joder-Ohlenbusch A-M, Grove J (1978b) Effects of ornithine decarboxylase inhibitors on cultured cells. In: Seiler N, Jung MJ, Koch-Weser J (eds) Substrate-induced irreversible inhibitors. Elsevier/North Holland Biomedical Press, Amsterdam, pp 43–54
Marton LJ, Levin VA, Hervatin SJ, Koch-Weser J, McCann PP, Sjoerdsma A (1981) Potentiation of the antitumoral therapeutic effects of 1,3-bis (2-chloroethyl)-1-nitrosourea by α-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41: 4426–4431
Maudsley DV (1979) Regulation of polyamine biosynthesis. Biochem Pharmacol 28:153–161
Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP (1978) Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J Am Chem Soc 100:2551–2553
Pearson OH, Manni A (1978) Hormonal control of breast cancer growth in women and rats. In: Martini L, James VHT (eds) Current topics in experimental endocrinology, vol 3. Academic Press, New York, pp 75–92
Prakash NJ, Schechter PJ, Grove J, Koch-Weser J (1978) Effect of α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase on L1210 leukemia in mice. Cancer Res 38:3059–3062
Prakash NJ, Schechter PJ, Mamont PS, Grove J, Koch-Weser J, Sjoerdsma A (1979) Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis: effects of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Life Sci 26:181–194
Seiler N, Danzin C, Prakash NJ, Koch-Weser J (1978) Effects of ornithine decarboxylase inhibitors in vivo. In: Seiler N, Jung MJ, Koch-Weser J (eds) Substrate-induced irreversible inhibitors. Elsevier/North Holland Biomedical Press, Amsterdam, pp 55–71
Tabor CW, Tabor H (1976) 1,4-Diaminobutane (putrescine), spermidine, and spermine. Ann Rev Biochem 45:285–306
Williams-Ashman HG, Canellakis ZN (1979) Polyamines in mammalian biology and medicine. Perspect Biol Med 22:421–453
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fozard, J.R., Prakash, N.J. Effects of dl-α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene. Naunyn-Schmiedeberg's Arch. Pharmacol. 320, 72–77 (1982). https://doi.org/10.1007/BF00499076
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499076